The Marking Minute with Presco
The Rural Digital Opportunity Fund, or RDOF, enacted in 2019, provides $20.4 billion in funding for rural broadband construction over ten years. Complementing this fund, the newly enacted Infrastructure and Jobs Act promises to bring much relief to the nation in similar projects. With the next decade primed for a flurry of activity, it’s…
Latest
Business Services
Building a Career at Presco
While many companies look at positions as just job,. Presco commits to providing careers for its workforce. The Marking Minute host Daniel Litwin chatted with Kelly Brown, HR Representative, to learn more.
Business Services
Navigating Supply Chain Issues adn Extended Lead Times
Supply chain delays have been in the headlines since early 2021. “It’s something we’re discussing and having conversations about on a day-to-day basis. It’s been crazy. No market, no industry appears immune from the challenges,” said Michael Smith, Business Development Manager at Presco. Presco is a part of its larger parent company, Trident. Trident has…
Episodes - Marking Minute
Marking Minute News: The Mulch Film Market is Growing
The market for biodegradable mulch film is growing rapidly according to a new report out from Market Study Report, LLC. The Global Biodegradable Mulch Film Market is expected to rise from its initial estimated value of nearly $42 billion in 2018 to an estimated value of 77 billion by 2026. These mulch films are attractive…
Episodes - Marking Minute
Presco Safeguard Drapery: A Barrier from COVID-19
The battle to suppress COVID-19 has been raging on for months across the world, and the best offense has proven to be a good defense. However, it’s the health workers on the front lines who are in the greatest need of defending, and Presco is here with an arsenal of PPE (Personal Protective Equipment) to…
Community Generated Content - Trident Solutions
The Marking Minute -Presco: Fiber-Build and FTTH Project Space
When the onset of the pandemic pushed everyone back into their homes, one of our greatest assets became having uninterrupted access to the internet. While fiber to the home initiatives (FTTH) were on the up and coming prior to COVID-19, the pandemic brought a slush of funding and attention to the industry. National Account Manager…
Business Services
Marking Minute: How Do Our Products Fit in the RDOF and Utility Infrastructure Bill
Trident family hassolutions to assist theRDOF and Infrastructure Investment and Jobs Actinitiatives. KEY POINTS: Remote work & education needs accelerate rural broadband access advocacy. Trident Solutions’ products play a critical role in protecting and identifying utility assets. The Clean Water and Drinking Fund appropriated $15B into lead service lines and replacements. The Rural Digital Opportunity Fund, or RDOF, enacted in 2019, provides $20.4…
Latest
Analyzing the Suppressive TME in In Vitro Based Assays
In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…
Targeting T Cells Within the Cancer Immunity Cycle
As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…
Inside Oncology Drug Development: Overcoming Resistance with Science
In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…
